E2A translocations in pediatric leukemia: developing new therapeutic targets
|
Children’s Hospital of Philadelphia / Bruce Fischer, MD |
Young Investigator Grants |
2007 |
Pennsylvania |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia |
University of Pennsylvania / Kelly Getz, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center / Emmanuel Volanakis |
Young Investigator Grants |
2011 |
Tennessee |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida / Catherine Flores, PhD |
Young Investigator Grants |
2015 |
Florida |
Modeling the Initiation and Progression of Down Syndrome Associated Leukemia Using CRISPR/Cas9 at Single Cell Resolution |
Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD |
Young Investigator Grants |
2020 |
New York |
Targeted Polymeric Parthenolide Carriers to Treat Childhood AML |
University of Rochester / Danielle Benoit |
Young Investigator Grants |
2010 |
New York |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.
|
The Johns Hopkins University School of Medicine / Heather Symons |
Young Investigator Grants |
2009 |
Maryland |
Preclinical Efficacy of Daratumumab in T Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Karen Bride, MD/PhD |
Young Investigator Grants |
2017 |
New York |